We also found that PPP2R5C siRNA could inhibit the proliferation of primary CML cells in limited experiments, and this effect should be further explored using a larger patient cohort. This evidence concerns the gene PPP2R5C and chronic myelogenous leukemia, BCR-ABL1 positive.